Digital Journal
Lexaria Bioscience (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study
PRESS RELEASE Published May 24, 2024 InvestorBrandNetwork Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug-delivery pla...
23 hours ago